Striking similarities in the presentation and duration of illness of influenza A and B in the community: A study based on sentinel surveillance networks in France and Turkey, 2010-2012

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Cohen, Jean Marie ^a,b   Silva, Maria Laura ^a   Caini, Saverio ^a   Ciblak, Meral ^c   Mosnier, Anne ^a,b   Daviaud, Isabelle ^a   Matias, Gonçalo ^d   Badur, Selim ^c   Valette, Martine ^e   Enouf, Vincent ^f   Paget, John ^g   Fleming, Douglas M ^h  

^a Open Rome (Organize and Promote Epidemiological Network)   (France)

^b Open Rome Coordination Nationale des Groupes Régionaux d'Observation de la Grippe   (France)

^c ISTANBUL UNIVERSITY   (Turkey)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e UNIVERSITÉ LYON 1   (France)

^f INSTITUT PASTEUR   (France)

^g NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^h ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; FRANCE; GROUPS BY AGE; HUMAN; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SENTINEL SURVEILLANCE; TURKEY (REPUBLIC); CLINICAL TRIAL; INFANT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROSPECTIVE STUDY; TIME FACTOR; TURKEY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; TIME FACTORS; TURKEY; YOUNG ADULT;

EID: 84947214524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139431     Document Type: Article

References (32)

1. Meijer A, Meerhoff TJ, Meuwissen LE, van der Velden J, Paget WJ, European Influenza Surveillance Scheme. Epidemiological and virological assessment of influenza activity in Europe during the winter 2005-2006. Euro Surveill. 2007; 12(9):E11-2. PMID: 17991413
2. Grant KA, Carville K, Fielding JE, Barr IG, Riddell MA, Tran T, et al. High proportion of influenza B characterises the 2008 influenza season in Victoria. Commun Dis Intell Q Rep. 2009; 33(3): 328-36. PMID: 20043604
3. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012; 8(1): 81-8. doi: 10.4161/hv.8.1.17623 PMID: 22252006
4. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010; 28 Suppl 4: D45-53. doi: 10.1016/j.vaccine.2010.08.028 PMID: 20713260
5. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012; 30(11):1993-8. doi: 10.1016/j.vaccine.2011. 12.098 PMID: 22226861
6. Pitman RJ, Nagy LD, Antonova E, Scott DA. Cost-Effectiveness Comparison Of Quadrivalent Versus Trivalent Influenza Vaccines In The United States. Value in Health. 2013; 16(3):A90.
7. Truyers C, Lesaffre E, Bartholomeeusen S, Aertgeerts B, Snacken R, Brochier B, et al. Computerized general practice based networks yield comparable performance with sentinel data in monitoring epidemiological time-course of influenza-like illness and acute respiratory illness. BMC Fam Pract. 2010; 11:24. doi: 10.1186/1471-2296-11-24 PMID: 20307266
8. Pérez-Farinós N, Ordobás M, García-Fernández C, García-Comas L, Cañellas S, Rodero I, et al. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. BMC Infect Dis. 2007; 7:59. PMID: 17570859
9. Van den Block L, Van Casteren V, Deschepper R, Bossuyt N, Drieskens K, Bauwens S, et al. Nationwide monitoring of end-of-life care via the Sentinel Network of General Practitioners in Belgium: the research protocol of the SENTI-MELC study. BMC Palliat Care. 2007; 6:6. PMID: 17922893
10. Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine. 2012; 30(7): 1371-8. doi: 10.1016/j.vaccine.2011.12.038 PMID: 22178524
11. Rozenbaum MH, van Hoek AJ, Fleming D, Trotter CL, Miller E, Edmunds WJ. Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ. 2012; 345: e6879. doi: 10.1136/bmj.e6879 PMID: 23103369
12. Silva ML, Perrier L, Späth HM, Grog I, Mosnier A, Havet N, et al. Economic burden of seasonal influenza B in France during winter 2010-2011. BMC Public Health. 2014; 14:56. doi: 10.1186/1471-2458-14-56 PMID: 24443900
13. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2010-2011 northern hemisphere influenza season. Available: http://www.who.int/influenza/vaccines/virus/recommendations/201002-Recommendation.pdf. Accessed 29 July 2013.
14. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Available: http://www.who.int/influenza/vaccines/2011-02-recommendation.pdf. Accessed 29 July 2013.
15. Hannoun C, Dab W, Cohen JM. A new influenza surveillance system in France: the Ile-de-France "GROG". 1. Principles and methodology. Eur J Epidemiol. 1989; 5(3): 285-93. PMID: 2792306
16. Ciblak MA, Hasoksuz M, Escuret V, Valette M, Gul F, Yilmaz H, et al. Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season. J Med Virol. 2009; 81(9): 1645-51. doi: 10.1002/jmv.21546 PMID: 19626608
17. World Health Organization (WHO). WHO Information for the molecular diagnosis of influenza virus in humans-update (August 2011). Available: http://www.who.int/influenza/resources/documents/molecular-diagnosis-influenza-virus-humans-update-201108.pdf. Accessed 29 July 2013.
18. French Code of Public Health. Articles L1122-1 and L1122-2. Available: http://www.legifrance.gouv.fr/. Accessed 24 January 2014.
19. General Directorate of Primary Health Care. Notification of infectious diseases-Standard identification and reporting system, surveillance and laboratory guide. Turkish Ministry of Health, Ankara. 4th edition. 2005.
20. European Centre for Disease Prevention and Control. Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. Stockholm: ECDC.
21. Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008. Influenza Other Respir Viruses. 2012; 6(1):37-43. doi: 10.1111/j.1750-2659.2011.00263.x PMID: 21668663
22. Daley AJ, Nallusamy R, Isaacs D. Comparison of influenza A and influenza B virus infection in hospitalized children. J Paediatr Child Health. 2000; 36(4):332-5. PMID: 10940165
23. Chiu SS, Chan KH, Chen H, Young BW, Lim W, Wong WH, et al. Virologically confirmed populationbased burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis. 2009; 49(7):1016-21. doi: 10.1086/605570 PMID: 19722912
24. Esposito S, Molteni CG, Daleno C, Valzano A, Fossali E, Da Dalt L, et al. Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. BMC Infect Dis. 2011; 11:271. doi: 10.1186/1471-2334-11-271 PMID: 21992699
25. Nitsch-Osuch A, Wozniak-Kosek A, Korzeniewski K, Zycinska K, Wardyn K, Brydak LB. Clinical features and outcomes of influenza A and B infections in children. Adv Exp Med Biol. 2013; 788:89-96. doi: 10.1007/978-94-007-6627-3-14 PMID: 23835964
26. Wie SH, So BH, Song JY, Cheong HJ, Seo YB, Choi SH, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: a multi-center study. PLoS One. 2013; 8(5): e62685. doi: 10.1371/journal.pone.0062685 PMID: 23671624
27. Cohen AL, Hellferscee O, Pretorius M, Treurnicht F, Walaza S, Madhi S, et al. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014; 20(7):1162-9. doi: 10.3201/eid2007.131869 PMID: 24960314
28. Yap J, Tan CH, Cook AR, Loh JP, Tambyah PA, Tan BH, et al. Differing clinical characteristics between influenza strains among young healthy adults in the tropics. BMC Infect Dis. 2012; 12:12. doi: 10.1186/1471-2334-12-12 PMID: 22264216
29. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med. 2014; 2(6):445-54. doi: 10.1016/S2213-2600(14)70034-7 PMID: 24717637
30. Public Health Council. Antivirals use during circulation of the A(H1N1)pdm09 virus [in French]. Available: http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=243. Accessed 17 July 2015.
31. Influenza Expertise and Information Group [in French]. Available: http://www.grippe-geig.com/webapp/website/website.html?id=2535762. Accessed 17 July 2015.
32. Ciblak MA; Grip Platformu. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013; 31(3):518-23. doi: 10.1016/j.vaccine.2012.11.022 PMID: 23174194